Loading…

PROLONGED DONOR HEART CORRECTED QT INTERVAL: IS THERE A RISK?

Post-Htx outcomes included 1-yr survival, 1-yr freedom from any treated rejection, 1-yr freedom from CAV defined as stenosis >= 30%, and 1-yr freedom from Non-Fatal Major Adverse Cardiac Events (NF-MACE: myocardial infarction, new congestive heart failure, percutaneous coronary intervention, impl...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.1372-1372
Main Authors: Leong, Derek, Aintablian, Tamar, Kittleson, Michelle, Patel, Jignesh, Chang, David, Kobashigawa, Jon
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Post-Htx outcomes included 1-yr survival, 1-yr freedom from any treated rejection, 1-yr freedom from CAV defined as stenosis >= 30%, and 1-yr freedom from Non-Fatal Major Adverse Cardiac Events (NF-MACE: myocardial infarction, new congestive heart failure, percutaneous coronary intervention, implantable cardioverter defibrillator/pacemaker implant, stroke).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(16)31373-0